Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant
(Reuters) -Elon Musk’s brain-chip startup Neuralink said on Tuesday its implant aimed at restoring vision received the U.S. Food and Drug Administration’s “breakthrough device” designation. The FDA’s breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. It is aimed at speeding up development and review of experimental devices….
